Post COVID fatigue: AETL’ supplements pass trials
The Hindu
Study was conducted on 200 patients across three centres
Advanced Enzyme Technologies Ltd (AETL) has said its systemic enzyme and probiotic supplements—ImmunoSEB and ProbioSEB CSC3 have passed the randomised controlled clinical trials in terms of efficacy to resolve post COVID-19 fatigue symptoms. “With an aim to evaluate the efficacy and safety of the health supplements, ImmunoSEB [systemic enzyme complex] and ProbioSEB CSC3 [probiotic complex] in patients suffering from COVID-19 induced fatigue, a randomised, multi-centric, double blind and placebo-controlled trial was conducted in 200 patients suffering from post COVID-19 fatigue symptoms,” said Dr. Abhijit K. Rathi, Principal Scientist, AETL. “The randomized clinical trial was conducted on 200 patients who did not have an active SARS-CoV-2 infection, as determined by a negative COVID-19 test, with a complaint of post COVID-19 fatigue,” he stated.More Related News
PM Modi’s meditation in Kanniyakumari continues; tourists allowed to visit Vivekananda Rock Memorial
Prime Minister Modi meditates at Vivekananda Rock Memorial, with tight security measures impacting tourism in Kanniyakumari.